Related Experiment Video
Updated: Jul 23, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
Autonomous rexinoid death signaling is suppressed by converging signaling pathways in immature leukemia cells
G R Benoit1, M Flexor, F Besançon
1INSERM U-496, Centre G. Hayem Hôpital Saint-Louis 75010 Paris, France.
Abstract:
On their own, retinoid X receptor (RXR)-selective ligands (rexinoids) are silent in retinoic acid receptor (RAR)-RXR heterodimers, and no selective rexinoid program has been described as yet in cellular systems. We report here on the rexinoid signaling capacity that triggers apoptosis of immature promyelocytic NB4 cells as a default pathway in the absence of survival factors. Rexinoid-induced apoptosis displays all features of bona fide programmed cell death and is inhibited by RXR, but not RAR antagonists. Several types of survival signals block rexinoid-induced apoptosis. RARalpha agonists switch the cellular response toward differentiation and induce the expression of antiapoptosis factors. Activation of the protein kinase A pathway in the presence of rexinoid agonists induces maturation and blocks immature cell apoptosis. Addition of nonretinoid serum factors also blocks cell death but does not induce cell differentiation. Rexinoid-induced apoptosis is linked to neither the presence nor stability of the promyelocytic leukemia-RARalpha fusion protein and operates also in non-acute promyelocytic leukemia cells. Together our results support a model according to which rexinoids activate in certain leukemia cells a default death pathway onto which several other signaling paradigms converge. This pathway is entirely distinct from that triggered by RAR agonists, which control cell maturation and postmaturation apoptosis.
Insights
Selective rexinoids trigger apoptosis in immature leukemia cells as a default pathway. This programmed cell death is distinct from retinoic acid receptor (RAR) signaling, which promotes differentiation.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Retinoid X receptors (RXRs) form heterodimers with retinoic acid receptors (RARs).
- Selective RXR ligands (rexinoids) were previously considered silent in these heterodimers.
- No selective rexinoid signaling pathway had been described in cellular systems.
Purpose of the Study:
- To investigate the signaling capacity of rexinoids independently of RARs.
- To identify cellular pathways activated by selective rexinoids.
- To characterize the cellular response to rexinoids in leukemia cells.
Main Methods:
- Utilized NB4 promyelocytic leukemia cells.
- Administered selective rexinoid agonists and antagonists.
- Investigated apoptosis induction and inhibition.
- Examined the effects of survival signals, RAR agonists, and protein kinase A activation.
Main Results:
- Rexinoids trigger apoptosis in immature NB4 cells as a default pathway in the absence of survival factors.
- Rexinoid-induced apoptosis exhibits characteristics of programmed cell death and is inhibited by RXR antagonists.
- Survival signals, RARalpha agonists, and protein kinase A activation block rexinoid-induced apoptosis.
- Rexinoid-induced apoptosis is independent of the promyelocytic leukemia-RARalpha fusion protein.
Conclusions:
- Rexinoids activate a distinct default death pathway in certain leukemia cells.
- This rexinoid-activated pathway converges with other signaling paradigms.
- The rexinoid pathway is separate from the RAR agonist pathway that controls cell maturation and postmaturation apoptosis.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Differentiation of Common Myeloid Progenitor Cells
Regulation of Hematopoietic Stem Cells
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

